Found: 78
Select item for more details and to access through your institution.
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 5, p. 553, doi. 10.3390/ph17050553
- By:
- Publication type:
- Article
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1529, doi. 10.3390/ph15121529
- By:
- Publication type:
- Article
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1197340
- By:
- Publication type:
- Article
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.792609
- By:
- Publication type:
- Article
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 256, doi. 10.1111/bjh.19518
- By:
- Publication type:
- Article
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 187, doi. 10.1111/bjh.18502
- By:
- Publication type:
- Article
Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 649, doi. 10.1111/bjh.17888
- By:
- Publication type:
- Article
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
- By:
- Publication type:
- Article
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 299, doi. 10.1111/bjh.17138
- By:
- Publication type:
- Article
Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 181, doi. 10.1111/bjh.16796
- By:
- Publication type:
- Article
Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstrom macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 849, doi. 10.1111/bjh.14266
- By:
- Publication type:
- Article
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 547, doi. 10.1111/bjh.14708
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 404, doi. 10.1111/bjh.14549
- By:
- Publication type:
- Article
Extramedullary disease in multiple myeloma in the era of novel agents.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Clinical applicability and prognostic significance of molecular response assessed by fluorescent- PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/ PETHEMA study.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 581, doi. 10.1111/bjh.12576
- By:
- Publication type:
- Article
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 223, doi. 10.1111/bjh.12519
- By:
- Publication type:
- Article
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen ( RIC) and post-allogeneic transplantation for high-risk myeloma patients.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 474, doi. 10.1111/bjh.12410
- By:
- Publication type:
- Article
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507
- By:
- Publication type:
- Article
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 609, doi. 10.1007/s00277-023-05542-6
- By:
- Publication type:
- Article
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 12, p. 2997, doi. 10.1007/s00277-021-04653-2
- By:
- Publication type:
- Article
Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 107, doi. 10.1007/s00277-013-1942-7
- By:
- Publication type:
- Article
Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2567, doi. 10.3390/cancers16142567
- By:
- Publication type:
- Article
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1689, doi. 10.3390/cancers16091689
- By:
- Publication type:
- Article
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5261, doi. 10.3390/cancers15215261
- By:
- Publication type:
- Article
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5169, doi. 10.3390/cancers14205169
- By:
- Publication type:
- Article
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5131, doi. 10.3390/cancers13205131
- By:
- Publication type:
- Article
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4924, doi. 10.3390/cancers13194924
- By:
- Publication type:
- Article
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2055, doi. 10.3390/cancers13092055
- By:
- Publication type:
- Article
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 504, doi. 10.1111/ejh.13835
- By:
- Publication type:
- Article
The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241778
- By:
- Publication type:
- Article
Acquired Fanconi Syndrome Secondary to Monoclonal Gammopathies: A Case Series From a Single Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 614, doi. 10.1016/j.clml.2013.04.008
- By:
- Publication type:
- Article
Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 5, p. 389, doi. 10.1111/ejh.13217
- By:
- Publication type:
- Article
Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 340, doi. 10.1111/j.1600-0609.2012.01821.x
- By:
- Publication type:
- Article
Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures de Larrea et al. Bilateral plasmablastic myeloma arising from humeral fractures.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 448, doi. 10.1111/j.1600-0609.2010.01504.x
- By:
- Publication type:
- Article
Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 2, p. 182, doi. 10.1111/j.1600-0609.2007.01005.x
- By:
- Publication type:
- Article
Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 6, p. 486, doi. 10.1111/j.0902-4441.2006.t01-1-EJH2783.x
- By:
- Publication type:
- Article
Bortezomib: an effective agent in extramedullary disease in multiple myeloma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 5, p. 405, doi. 10.1111/j.0902-4441.2005.t01-1-EJH2462.x
- By:
- Publication type:
- Article
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance.
- Published in:
- Current Treatment Options in Oncology, 2006, v. 7, n. 3, p. 237, doi. 10.1007/s11864-006-0016-7
- By:
- Publication type:
- Article
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
- By:
- Publication type:
- Article
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 635, doi. 10.1016/j.clml.2022.04.014
- By:
- Publication type:
- Article
Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e241, doi. 10.1016/j.clml.2021.10.001
- By:
- Publication type:
- Article
P-217: Isatuximab plus Carfilzomib and Dexamethasone in relapsed Multiple Myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S159, doi. 10.1016/S2152-2650(21)02344-2
- By:
- Publication type:
- Article
P-206: SELECT Trial in Progress: an open-label, phase 2 study of Carfilzomib, Pomalidomide, and Dexamethasone in patients with first or second relapse of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S152, doi. 10.1016/S2152-2650(21)02333-8
- By:
- Publication type:
- Article
P-179: Immunoparesis remains a negative prognostic factor in newly diagnosed Multiple Myeloma by competing risk analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02306-5
- By:
- Publication type:
- Article
P-169: Outcome of non-transplant eligible patients with newly diagnosed multiple myeloma depending on the eligibility for clinical trials: a single institution experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S128, doi. 10.1016/S2152-2650(21)02296-5
- By:
- Publication type:
- Article
P-124: The history of survival improvement in patients with Multiple Myeloma through real-world data in a 45-year period at a single institution.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S102, doi. 10.1016/S2152-2650(21)02251-5
- By:
- Publication type:
- Article
P-032: Clinical characteristics and outcome of 30 patients with poems syndrome in Catalonia: impact of autologous stem cell transplantation in first line and at relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S55, doi. 10.1016/S2152-2650(21)02166-2
- By:
- Publication type:
- Article
MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S420, doi. 10.1016/S2152-2650(21)01942-X
- By:
- Publication type:
- Article
Poster: MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S250, doi. 10.1016/S2152-2650(21)01570-6
- By:
- Publication type:
- Article
Bone Marrow Plasma Cell Infiltration in Light-Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S236, doi. 10.1016/j.clml.2018.07.122
- By:
- Publication type:
- Article